Efficacy of fesoterodine fumarate (8 mg) in neurogenic detrusor overactivity due to spinal cord lesion or multiple sclerosis: A prospective study.
Charalampos KonstantinidisMichael SamarinasMoira TzitzikaZisis KratirasGeorgios PanagiotakopoulosKonstantinos GiannitsasAnastasios AthanasopoulosPublished in: Neurourology and urodynamics (2021)
Fesoterodine fumarate (8 mg) is an efficacious drag in patients with SCL and MS, as it significantly decreases the detrusor pressure, increases the bladder capacity and compliance, and improves the QoL.